Japan Chemical Daily

Japan's leading chemical industry newspaper

CDMO

Sumitomo Dainippon Pharma to Expand Regenerative and Cellular Medicine CDMO Operations

Jun. 8, 2022

Sumitomo Dainippon Pharma Co. Ltd. (TYO:4506) and Sumitomo Chemical Co. Ltd. (TYO:4005) plan to expand their CDMO facilities for regenerative…...

Please subscribe to read the full story.

Subscribe Free Trial

Asahi Kasei Medical to Enter Pharmaceutical CDMO Business

Apr. 22, 2022

Asahi Kasei Medical Co. Ltd. recently announced that it will acquire California-based Bionova Scientific LLC, a CDMO for biopharmaceuticals. The…...

Please subscribe to read the full story.

Subscribe Free Trial

AGC Plans to Invest Over 200B Yen in CDMO Operations for Gene & Cell Therapy, More

Mar. 15, 2022

AGC Inc. (TYO:5201) is looking to invest more than 200 billion yen ($1.7 billion) into CDMO operations by 2025. Plans…...

Please subscribe to read the full story.

Subscribe Free Trial

Mitsui Chemicals to Re-Enter Nucleic Acid Drug CDMO Market

Mar. 7, 2022

Chitose Bio Evolution Moves Forward on Chemical, Bio-CDMO Mass Production in Japan

Feb. 17, 2022

Taiwan Looks to Establish CDMOs for mRNA Technology

Oct. 22, 2021

AGC in Race to Bolster CDMO Operations Across US, Europe and Japan

Jul. 2, 2021

Japan Looks to Catch the West as Opportunities Open up for mRNA Pharmaceuticals

Jun. 29, 2021

Japanese Chemical Companies Find Special Demand for Bio-CDMO Operations Amid COVID-19

Jun. 1, 2021

Raw Material Shortages Create Difficulties in Biopharma Production

Apr. 9, 2021

Sekisui Chemical to Build New Biopharmaceutical Plant in UK

Aug. 26, 2020

Coronavirus Report – Part 89: Japanese Materials and Chemicals Companies See Rush of Contract Production Activity

Jun. 9, 2020

Hitachi Chemical Plans European Medical Supplies Base

Jan. 12, 2018

Asahi Glass Announces Acquisition of Major European Biotech Pharmaceutical Company

Dec. 23, 2016